Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
This app is intended to assess the risks of prostate cancer (PC) progression after surgical treatment in patients with localized and locally advanced processes. Based on a comprehensive analysis of pre- and postoperative prognostic factors, this application allows to assess and predict the risks of biochemical progression of the disease and use the result to plan subsequent adjuvant therapy in a cohort of patients with high risk of progression after surgery. For patients: This application does not provide a diagnosis; it only predicts the risk of prostate cancer progression. We do not recommend taking any medications. We are not responsible for the misuse of our application. If you are not a doctor, consult a specialist for interpretation of the results obtained, as well as possible correction of treatment. For specialists (oncologist, urologist): Using this application, you can predict the risk of prostate cancer progression with high accuracy, which will allow you to develop further tactics for managing your patients - the result obtained can be used to prescribe further adjuvant therapy or keep the patient under active supervision.
